05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
The Hong Kong Stock Exchange continues to pursue and implement a number of rule changes aimed at mak...
Read More >
Our Virtual Regional Compliance Conferences provide updates on the latest news in regulatory require...
Read More >
By September 30, 2019, employers with 100 or more employees are required to submit certain pay data ...
Read More >
The definition earnings before interest, taxes, depreciation and amortization (“EBITDA”) and adjus...
Read More >
Food Services Supplier Failed to Promote Female Employee to Sous Chef, Federal Agency Alleged - HO...
Read More >
Employers often allow employees to donate leave to co-workers who are experiencing medical emergenci...
Read More >